How did smokers respond to standardised cigarette packaging with new, larger health warnings in the United Kingdom during the transition period? A cross-sectional online survey.

Tobacco packaging and labelling public policy

Journal

Addiction research & theory
ISSN: 1606-6359
Titre abrégé: Addict Res Theory
Pays: England
ID NLM: 101122095

Informations de publication

Date de publication:
2020
Historique:
entrez: 30 1 2020
pubmed: 30 1 2020
medline: 30 1 2020
Statut: ppublish

Résumé

In the United Kingdom, standardised packaging for cigarettes was phased in between May 2016 and May 2017. We assessed whether there was an association between using standardised packs and warning salience, thoughts about the risks of smoking, thoughts about quitting, and awareness and use of stop-smoking websites. We conducted a cross-sectional online survey with current smokers aged 16 and over ( Most participants reported currently using standardised packs (76.4%), 9.3% were not currently using them but had previously used them, and 14.3% had never used them. Compared with never users, current users were more likely to have noticed the warnings on packs often/very often (AOR (95%CI) = 2.76 (2.10, 3.63)), read them closely often/very often (AOR(95%CI) = 2.16 (1.51, 3.10)), thought somewhat/a lot about the health risks of smoking (AOR(95%CI) = 1.92 (1.38, 2.68)), and thought somewhat/a lot about quitting (AOR(95%CI) = 1.90 (1.30, 2.77)). They were also more likely to have noticed a stop-smoking website on packs. Consistent with the broad objectives of standardised packaging, we found that it was associated with increased warning salience and thoughts about risks and quitting.

Identifiants

pubmed: 31992964
doi: 10.1080/16066359.2019.1579803
pmc: PMC6986913
mid: EMS84603
doi:

Types de publication

Journal Article

Langues

eng

Pagination

53-61

Subventions

Organisme : Cancer Research UK
ID : A19748
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/K023195/1
Pays : United Kingdom

Déclaration de conflit d'intérêts

Disclosure staement EP, who commented on the manuscript, works for Cancer Research UK, which funded this study. The remaining authors have no interests to declare.

Références

Drug Alcohol Depend. 1994 Feb;34(3):211-6
pubmed: 8033758
J Public Health (Oxf). 2018 Dec 1;40(4):797-805
pubmed: 29155951
Soc Sci Med. 2016 Sep;164:118-129
pubmed: 27423739
Tob Control. 2015 Apr;24(Suppl 2):ii42-ii49
pubmed: 28407611
Eur Respir J. 2017 Nov 22;50(5):
pubmed: 29167302
Tob Control. 2019 Sep;28(5):485-492
pubmed: 30068563
BMJ Open. 2013 Jul 22;3(7):null
pubmed: 23878174
Cochrane Database Syst Rev. 2017 Apr 27;4:CD011244
pubmed: 28447363
Tob Control. 2016 Mar;25(2):181-7
pubmed: 25700365
Tob Control. 2016 Dec;25(e2):e120-e126
pubmed: 27091642
Tob Control. 2018 Nov;27(6):696-697
pubmed: 29180533
Tob Control. 2018 Jul;27(e1):e85-e92
pubmed: 29321273
Tob Control. 2018 Sep;27(5):513-518
pubmed: 28887428
Annu Rev Public Health. 2012 Apr;33:341-56
pubmed: 22224888
Subst Abuse Rehabil. 2016 May 18;7:55-69
pubmed: 27274333
Nicotine Tob Res. 2019 Jun 21;21(7):871-878
pubmed: 29342304
Int J Environ Res Public Health. 2017 Jul 31;14(8):
pubmed: 28788103
Nicotine Tob Res. 2019 Feb 18;21(3):309-313
pubmed: 30202853

Auteurs

Crawford Moodie (C)

Institute for Social Marketing, Faculty of Health Sciences and Sport, University of Stirling, Stirlingshire, Scotland, UK.
UK Centre for Tobacco & Alcohol Studies, Nottingham, UK.

Leonie S Brose (LS)

UK Centre for Tobacco & Alcohol Studies, Nottingham, UK.
Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.

Hyun S Lee (HS)

GKT School of Medical Education, King's College London, London, UK.

Emily Power (E)

Health Behaviour Research Centre, Cancer Research UK, London, UK.

Linda Bauld (L)

UK Centre for Tobacco & Alcohol Studies, Nottingham, UK.
Usher Institute, College of Medicine and Veterinary Medicine, University of Edinburgh, Edinburgh, UK.

Classifications MeSH